Cristal Therapeutics
Cristianne Rijcken is the CSO and founder of Cristal Therapeutics. Cristianne has over fifteen years of experience in the pharmaceutical and biotech industry. Prior to Cristal, they were the CEO and founder of Enceladus Pharmaceuticals. From 2008 to 2009, they served as a formulation scientist at Enceladus. From April 2019 to September 2020, they were a mentor at Talent Accelerator Programme for Biobusiness. Cristianne has also worked as a researcher at Proctor & Gamble and as a student intern at Schering-Plough Research Institute.
Cristianne Rijcken has a PharmD from Universiteit Utrecht, and also studied at private and de Baak. Cristianne is currently completing a Niaba - Masterclass BioBusiness at Instituut Maria Opdracht.
This person is not in any offices
Cristal Therapeutics
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.